RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000084.xml
Synthesis 2014; 46(07): 899-908
DOI: 10.1055/s-0033-1340679
DOI: 10.1055/s-0033-1340679
paper
Synthesis of 2-(4-Isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-ol; A Quinoline Building Block for Simeprevir Synthesis
Weitere Informationen
Publikationsverlauf
Received: 07. November 2013
Accepted after revision: 08. Januar 2014
Publikationsdatum:
30. Januar 2014 (online)
Dedicated to my friend and admirable human being Dr. Alfred Bader on the occasion of his 90th birthday (S.R.).
Abstract
Two synthetic approaches to the achiral quinoline fragment of simeprevir are described. Both approaches are based on the synthesis of methyl 4-hydroxy-7-methoxy-8-methylquinoline-2-carboxylate, protection of its 4-hydroxyl group, and construction of the thiazole ring from the ester group at the 2-position. The last step is acid deprotection of the 4-hydroxyl protecting group.
Supporting Information
- for this article is available online at http://www.thieme-connect.com/ejournals/toc/synthesis.
- Supporting Information
-
References
- 1 Raboisson P, de Kock H, Rosenquist L, Nilsson M, Salvador-Oden L, Lin T.-I, Roue N, Ivanov V, Wähling H, Wickström K, Hamelink E, Edlund M, Vrang L, Vendeville S, Van de Vreken W, McGowan D, Tahri A, Hu L, Boutton C, Lenz O, Delouvroy F, Pille G, Surleraux D, Wigerinck P, Samuelsson B, Simmen K. Bioorg. Med. Chem. Lett. 2008; 18: 4853
- 2 Kazmierski WM, Hamatake R, Duan M, Wright LL, Smith GK, Jarvest RL, Ji J.-J, Cooper JP, Tallant MD, Crosby RM, Creech K, Wang A, Li X, Zhang S, Zhang Y.-K, Liu Y, Ding CZ, Zhou Y, Plattner JJ, Baker SJ, Bu W, Liu L. J. Med. Chem. 2012; 55: 3021
- 3a Raboisson P, De Kock Vendeville SM, Hu L, Van De Vreken W, Mc Gowan DC, Tahri A, Surleraux DL, Simmen KA (Tibotec Pharm.) WO 2007/014919, Chem. Abstr. 2007, 146, 206645.
- 3b Raboisson P, De Kock Hu L, Vendeville SM, Tahri A, Surleraux DL, Simmen KA, Nilsson KM, Samuelsson BB, Rosenquist AA, Ivanov V, Pelcman M, Belfrage AK, Johansso P.-OM (Tibotec Pharm.) WO 2007/014926, Chem. Abstr. 2007, 146, 206646.
- 3c Cooper JP, Duan M, Grimes RM (GlaxoSmithKline) WO 2010/088394, Chem. Abstr. 2010, 153, 260655.
- 3d Buckman B, Nicholas JB, Beigelman L, Serebryany V, Stoycheva AD, Thrailkill T, Seiwert SD (Intermune, Inc.) WO 2011/038293, Chem. Abstr. 2011, 154, 435209.
- 3e Parsy CC, Alexandre F.-R, Leroy F, Convard T, Surleraux D (Idenix Pharm.) WO 2011/01738, Chem. Abstr. 2011, 154, 259414.
- 4a Unangst PC, Connor DT. J. Heterocycl. Chem. 1992; 29: 1097
- 4b Linas-Brunet ML, Bailey MD, Goudreau N, Bhardwaj PK, Bordeleau J, Bös M, Bousquet Y, Cordingley MG, Duan J, Forgione P, Garneau M, Ghiro E, Gorys V, Goulet S, Halmos T, Kawai SH, Naud J, Poupart MA, White PW. J. Med. Chem. 2010; 53: 6466
- 5 Guo Z, Dowdy ED, Li W.-S, Polniaszek R, Delaney E. Tetrahedron Lett. 2001; 42: 1843
- 6 Bergman J, Pettersson B, Hasimbegovic V, Svensson PH. J. Org. Chem. 2011; 76: 1546
- 7 Edmont D, Rocher R, Plisson C, Chenault J. Bioorg. Med. Chem. Lett. 2000; 10: 1831